Takeda Pharmaceutical Co Ltd (NYSE:TAK)
| 17.11 BATS BZX Real-Time Price As of 11:09am ET |  +0.11 / +0.65%Today’s Change | 15.30 Today|||52-Week Range 20.00 | -5.99% Year-to-Date |
Latest TAK News | Press Releases
| Is Morphic Holding a Buy? 6:50am / MotleyFool.com - Paid Partner Content | Why Molecular Templates Stock Crashed Today Apr 05 / MotleyFool.com - Paid Partner Content |
| Alexandria Real Estate Equities Is My Favorite Office REIT 6:40am / MotleyFool.com - Paid Partner Content | Supernus (SUPN) Receives FDA Approval for ADHD Treatment Apr 05 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 17.00 |
| Today’s open | 17.01 |
| Day’s range | 17.01 - 17.18 |
| Volume | 588,244 |
| Average volume (3 months) | 3,450,405 |
| Market cap | $54.0B |
Data as of 11:09am ET, 04/14/2021
Growth & Valuation
| Earnings growth (last year) | -74.46% |
| Earnings growth (this year) | +411.64% |
| Earnings growth (next 5 years) | +14.10% |
| Revenue growth (last year) | +60.06% |
| P/E ratio | 32.6 |
| Price/Sales | 1.57 |
| Price/Book | 1.23 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| REGNRegeneron Pharmaceut... | +5.23 | +1.10% |
| VRTXVertex Pharmaceutica... | +2.76 | +1.28% |
| ---- | ||
| ---- |
Data as of 11:10am ET, 04/14/2021
Financials
| Next reporting date | May 11, 2021 |
| EPS forecast (this quarter) | $0.32 |
| Annual revenue (last year) | $30.3B |
| Annual profit (last year) | $406.9M |
| Net profit margin | 1.34% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Osaka, Osaka |
Forecasts
